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Abstract
Objectives To investigate the knowledge of radiologists on breast arterial calcifications (BAC) and attitude about BAC reporting,
communication to women, and subsequent action.
Methods An online survey was offered to EUSOBI members, with 17 questions focused on demographics, level of experience,
clinical setting, awareness of BAC association with cardiovascular risk, mammographic reporting, modality of BAC assessment,
and action habits. Descriptive statistics were used.
Results Among 1084 EUSOBI members, 378 (34.9%) responded to the survey, 361/378 (95.5%) radiologists, 263 females
(69.6%), 112 males (29.6%), and 3 (0.8%) who did not specify their gender. Of 378 respondents, 305 (80.7%) declared to be
aware of BAC meaning in terms of cardiovascular risk and 234 (61.9%) to routinely include BAC in mammogram reports, when
detected. Excluding one inconsistent answer, simple annotation of BAC presence was declared by 151/233 (64.8%), distinction
between low versus extensive BAC burden by 59/233 (25.3%), and usage of an ordinal scale by 22/233 (9.5%) and of a cardinal
scale by 1/233 (0.4%). Among these 233 radiologists reporting BAC, 106 (45.5%) declared to orally inform the woman and, in case
of severe BAC burden, 103 (44.2%) to investigate cardiovascular history, and 92 (39.5%) to refer the woman to a cardiologist.
Conclusion Among EUSOBI respondents, over 80% declared to be aware of BAC cardiovascular meaning and over 60% to
include BAC in the report. Qualitative BAC assessment predominates. About 40% of respondents who report on BAC, in the
case of severe BAC burden, investigate cardiovascular history and/or refer the woman to a cardiologist.
Key Points
• Of 1084 EUSOBI members, 378 (35%) participated: 81% of respondents are aware of breast arterial calcification (BAC)
cardiovascular meaning and 62% include BAC in the mammogram report.
• Of those reporting BAC, description of presence was declared by 65%, low versus extensive burden distinction by 25%, usage
of an ordinal scale by 10%, and of a cardinal scale by 0.4%; 46% inform the woman and, in case of severe BAC burden, 44%
examine cardiovascular history, and 40% refer her to a cardiologist.
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• European breast radiologists may be ready for large-scale studies to ascertain the role of BAC assessment in the comprehen-
sive framework of female cardiovascular disease prevention.
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Introduction
Cardiovascular disease still represents the leading cause of
death for women [1]. Disparities in mortality rates still
subsist by sex among age groups, with less favourable
trends in young women [2, 3]. Recommended risk stratifi-
cation algorithms—including traditional risk factors, sex,
race, and ethnicity—do not adequately perform in women,
leading to potential risk underestimation and subsequent
undertreatment [4, 5]. Likely, traditional cardiovascular
risk factors actually confer different risks for women and
men. On the other hand, unique non-traditional risk factors
such as pregnancy complications, oral contraception, hor-
monal fertility, menopausal therapies, and systemic auto-
immune disorders play a crucial role in the complex bio-
logical pathway towards cardiovascular disease in women
[6]. Moreover, the estrogenic dysregulation occurring in
menopause—but also in premature ovarian insufficiency
and obesity—favours breast arterial calcifications (BAC)
development [7–10].
BAC on mammography are known to be strongly
associated with cardiovascular disease, independently
from other known cardiovascular risk factors [11], and
their inclusion in cardiovascular risk algorithms has
been advocated to improve cardiovascular outcomes in
women [12, 13]. The current strength of this associa-
tion, however, is not sufficient to warrant a clinical
application in preventive cardiology. Indeed, the lack
of validated and reproducible quantification methods
allowing for risk stratification still represents an open
issue. Nevertheless, no universal recommendations do
exist on whether and how to report BAC and how to
deal with them, discuss with women, or refer to cardi-
ologists [5, 7].
In this context, the European Society of Breast Imaging
(EUSOBI) launched a survey among its members to investi-
gate the radiologist attitude about BAC awareness, reporting,
communication, and actions. The results of this survey are
reported in this paper.
Materials and methods
Survey design and recipients
The surveywas developed by two board-certified radiologists,
one (F.S.) with over 30 years of experience in breast and
cardiovascular imaging and one (R.M.T.) with over 10 years
of experience in breast imaging. A biomedical engineer with a
background in image segmentation and survey methodology
(M.C.) contributed to the design. After approval from the
EUSOBI executive board, the questionnaire was published
online on a dedicated software platform (Google Forms,
Google). EUSOBI members were invited to anonymously
participate by an e-mail from the society’s central office that
included a link to the survey form. The self-administered
questionnaire was available for 5 weeks, from February 10
to March 17, 2020, with two e-mail reminders sent on
March 2 and March 15, 2020.
After a brief introduction about BAC and their associa-
tion with cardiovascular risk, ten questions focused on the
following: readers’ demographics (gender, age, geograph-
ical origin, job position) and experience (years in reading
mammography, reading in a population-based screening
mammography programme, number of mammograms read
per year, percentage of working time dedicated to breast
imaging); clinical setting (academic hospital, community
hospital, private hospital, private practice). Subsequently,
seven questions focused on whether participants had pre-
viously heard about the association between BAC and car-
diovascular risk and whether they describe BAC in mam-
mogram reports. If respondents indicated to include BAC
in the mammogram reports, a further question investigated
the method adopted for BAC assessment, distinguishing
between qualitative and quantitative methods, according
to whether visual subjective or numerical/objective evalu-
ations were performed. Action habits, namely discussing
with the woman her BAC status and, in case of severe
BAC burden or progression, investigating cardiovascular
anamnesis and/or referring to cardiologists, were also the
focus of specific questions. The entire questionnaire is pro-
vided as Supplementary material (ESM 1).
Statistical analysis
After survey closure onMarch 17, 2020, results were exported
in a spreadsheet for statistical analysis. Descriptive statistics
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were expressed as absolute frequencies and percentages for
categorical variables. To compare differences between vari-
ables, the chi-squared test was applied. Statistical analysis was
performed using R v3.5.3 forWindows (The R Foundation for
Statistical Computing).
Results
Demographics, experience, clinical setting, and job
position
Invitation e-mails were sent out to 1084 EUSOBI members,
reaching 1074 of them. The questionnaire was filled-in by 378
participants, yielding a 35.2% response rate. Among them,
263 (69.6%) were females, 112 were males (29.6%), and 3
(0.8%) did not specify their gender. Most of the respondents
were based in Europe (290/378, 76.7%), only 88/378 (23.2%)
in non-European countries, mainly Turkey (14/378, 3.7%).
Geographic origin was categorised in three different areas:
Western (233/378, 61.6%) and Eastern Europe (57/378,
15.1%) and non-European countries (Fig. 1).
Board-certified radiologists mainly responded to the survey
(361/378, 95.5%). Among them, 215 (59.6%) read in a
population-based screening mammography programme and
87 (24.1%) are fully dedicated to breast imaging. Further char-
acteristics of participants on demographics, experience, and
clinical setting are given in Table 1.
Awareness
Among the 378 respondents, 305 (80.7%) had heard about the
association between BAC on mammography and cardiovas-
cular risk. BAC awareness did not significantly differ among
gender, geographic origin, clinical setting, job position, years
of experience in reading mammography, number of mammo-
grams read per year, and percentage of working time dedicat-
ed to breast imaging (p ≥ 0.101). Age and reading in a
population-based screening mammography programme were
associated with the knowledge of BAC cardiovascular mean-
ing (p = 0.045 and p = 0.020, respectively). Respondents over
50 years were more frequently aware (131/153, 85.6%) com-
pared with younger breast radiologists (174/225, 77.3%),
while 76.8% (172/224) of those reading in a population-
based screening mammography programme were aware of
BAC meaning compared with 86.4% (133/154) of radiolo-
gists not involved in a population-based screening
programme.
Reporting
Over 60% of respondents (234/378, 61.9%) include BAC in
the mammogram reports; 64.9% (198/305) of those aware of
BAC cardiovascular meaning declared to report BAC com-
pared with 49.3% (36/73) of those unaware (p = 0.014).
Attitude towards BAC reporting was not significantly in-
fluenced by gender, age, geographic origin, job position, years
Fig. 1 Geographic origin of participants to the survey, grouped by three different areas. Countries with less than two respondents were not plotted
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of experience in reading mammography, and percentage of
working time dedicated to breast imaging (p ≥ 0.588). BAC
reporting was associated to clinical setting and number of
mammograms read per year (p < 0.001), as well as to reading
in a population-based screening mammography programme
(p = 0.037); 83.6% (51/61) of radiologists based in private
practice and 66.7% (50/75) of those based in private hospitals
use to report BAC, compared with 49.4% (41/83) of those
based in community hospitals and 56.6% (86/152) of those
based in academic hospitals; 68.3% (177/259) of respondents
with a mammography workload under 5000 examinations per
year and 68.2% (105/154) of those not reading in a
population-based screening mammography programme de-
clared to report BAC compared with 47.9% (57/119) of re-
spondents having an annual mammography workload over
5000 examinations and 57.6% (129/224) of radiologist
readers of population-based screening mammography.
Association of BAC awareness and reporting with respon-
dents’ demographics and experience are detailed in Table 2.
Assessment methods
Out of 234 responders who report BAC, one respondent gave
an inconsistent answer that was excluded. Simple annotation
of BAC presence was declared by 151/233 (64.8%), distinc-
tion between low versus extensive BAC burden by 59/233
(25.3%), usage of an ordinal scale by 22/233 (9.5%) and of
a cardinal scale by 1/233 (0.4%). No respondent indicated the
use of software for quantitative assessment (Fig. 2). The
choice of the modality of assessment was not influenced by
radiologists’ geographic origin, clinical setting, and experi-
ence (p ≥ 0.079). Gender and age were associated with the
use of a dichotomous assessment method (p < 0.001), with
female and younger than 50 years radiologists being more
prone to adopt a dichotomic present/absent assessment,
73.5% (119/162) and 75.2% (106/141) respectively compared
with 46.4% (32/69) males and 48.9% (45/92) radiologists over
50 years. Of note, 95/233 (40.8%) of respondents also evalu-
ate BAC evolution over time by comparing previous
examinations.
Action habits
Three questions aimed to investigate radiologists’ attitude
about communication of the BAC status to the woman and
eventual subsequent actions to be taken. Among the 233 re-
spondents reporting BAC, 106 (45.5%) orally inform the
woman, 50 (47.2%) only in case of severe BAC burden or
progression. Finally, in this case, 103/233 (44.2%) respon-
dents investigate personal or family history of cardiovascular
disease and 92/233 (39.5%) refer the woman to a cardiologist.
Overall, action habits were associated with respondents’
awareness about BAC, geographic origin, and clinical setting
(p ≤ 0.048). Moreover, respondents under 50 years were less
likely to communicate to the woman (p = 0.016) or to inves-
tigate cardiovascular anamnesis (p = 0.009). Action habits
were not associated with radiologists’ experience
(p ≥ 0.258). Significant associations of action habits with re-
spondents’ demographics and experience are detailed in
Table 3.






Not specified 3 0.8
Age
< 30 years 7 1.9
30–39 years 85 22.5
40–49 years 133 35.2
50–59 years 105 27.8
60–69 years 45 11.9






Academic hospital 152 40.2
Community hospital 83 22.0
Private hospital 75 19.8




< 2 years 17 4.5
2–5 years 50 13.2
6–10 years 94 24.9
11–20 years 110 29.1







> 5000 119 31.5





The response rate to this survey, reaching more than a
third of all EUSOBI members, shows a relatively high
interest of breast radiologists towards BAC. Over 80%
of participants were aware of the association between
BAC and cardiovascular risk and over 60% declared
to include BAC in mammography reports when they
are present. Such data show how even in an era of
highly specialised medicine and radiological subspe-
cialties, about 30% of EUSOBI members display a com-
prehensive approach towards disease prevention,
Table 2 Association of BAC
awareness and reporting with
respondents’ demographics and
experience
BAC awareness p BAC reporting p
Yes No Yes No
Demographics
Gender 0.176 0.983
Female 206 57 163 100
Male 96 16 69 43
Not specified 3 0 2 1
Age 0.045 0.588
< 50 years 174 51 142 83
≥ 50 years 131 22 92 61
Geographic origin 0.599 0.827
Western Europe 186 47 134 99
Eastern Europe 47 10 39 18
Non-EU countries 72 16 61 27
Job position 0.139 0.718
Radiologist 294 67 225 136
Resident 6 2 4 4
Fellow/PhD 5 4 5 4
Clinical setting 0.101 < 0.001
Academic hospital 129 23 86 66
Community hospital 59 24 41 42
Private hospital 59 16 50 25
Private practice 52 9 51 10
Other 6 1 6 1
Experience
Working time in breast imaging 0.401 0.796
0–99% 228 58 176 110
100% 77 15 58 34
Reading mammography 0.446 0.990
< 2 years 12 5 10 7
2–5 years 39 11 30 20
6–10 years 76 18 60 34
11–20 years 86 24 68 42
> 20 years 92 15 66 41
Mammograms per year 0.360 < 0.001
0–1999 103 29 93 39
2000–4999 101 26 84 43
> 5000 101 18 57 62
Screening reader 0.020 0.037
Yes 172 52 129 95





beginning to consider mammography as a tool that
could combine breast cancer prevention with cardiovas-
cular prevention in women.
There is robust evidence linking BAC with well-known
cardiovascular risk factors, such as increasing age, parity,
diabetes mellitus, and hyperlipidaemia, all associated with a
higher BAC prevalence [5, 7, 11] than that (12.7%) currently
reported among the general female population attending
breast cancer screening programmes [11]. Several studies sug-
gested that BAC presence is associated with a risk of coronary
Table 3 Association of action habits with respondents’ demographics and BAC awareness
Communication to the woman p Ask for CV anamnesis p Refer for a cardiology visit p
Yes No NR Yes No NR Yes No NR
Demographics
Age 0.016 0.009 0.191
< 50 years 55 85 2 53 88 2 51 89 2
≥ 50 years 51 41 0 50 41 1 41 50 1
Geographic origin 0.002 0.010 < 0.001
Western Europe 65 67 1 62 70 1 51 81 1
Eastern Europe 24 15 0 23 16 0 26 12 1
Non-EU countries 17 44 1 18 43 2 15 46 1
Clinical setting < 0.001 0.001 < 0.001
Academic hospital 28 58 0 34 52 1 26 59 1
Community hospital 10 30 0 9 30 1 7 32 1
Private hospital 32 17 1 28 22 1 25 25 1
Private practice 36 15 0 31 20 0 31 20 0
Other 0 6 0 1 5 0 3 3 0
BAC awareness 0.002 0.029 0.048
Yes 98 98 1 93 103 2 83 112 2
No 8 28 1 10 26 1 9 27 1
CV, cardiovascular; NR, no response
Fig. 2 Pie chart of BAC assessment modality as declared by 233 BAC reporters. No one indicated computerised methods
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heart disease up to three times higher than in the general pop-
ulation [8, 14–16], independently from other known cardio-
vascular risk factors and from the presence of coronary artery
disease [14, 15].
Notably, BAC and coronary atherosclerotic plaques are the
expression of two different pathophysiological processes.
While BAC are the consequence of Mönckeberg medial cal-
cific sclerosis—a non-occlusive disease resulting in thicker
and stiffer vessels—coronary plaques involve the vascular
intima, leading to luminal narrowing and vessel occlusion
[17].
This survey also revealed that, among radiologists reading
in a population-based screening mammography programme,
the majority is aware of BAC cardiovascular meaning and
includes BAC in mammogram reports (when BAC are pres-
ent), even if report forms, per se, do not provide such input.
This is a positive proactive behaviour. First of all, this im-
proves primary care physicians’ perception of BAC meaning
and potential. Secondly, it facilitates the creation of large
da tase t s , encourag ing prospec t ive s tudies wi th
known cardiovascular outcomes to ascertain if BAC may im-
prove cardiovascular risk stratification over traditional ap-
proaches. Finally, from the patient’s perspective, receiving
such information is desirable. A recent study centred on a
self-administered survey involving 419 women undergoing
screening or diagnostic mammography highlighted how
women have an overwhelming preference to be informed if
BAC are found in their mammograms [18]. Of note, while
cardiovascular risk awareness among women remains low
despite the high toll paid in terms of cardiovascular mortality
[19, 20], findings by Margolies et al [18] strongly hint that, if
properly informed, women would become actively involved
in tailored preventive strategies focused on cardiovascular dis-
ease, beginning to consider it not only as a “male problem”.
Oral communication with women about their BAC status is
pursued by 45.5% of respondents which routinely include
BAC in mammography reports, even though in 47.2% of
cases doing it only when BAC burden or progression is
deemed severe. If so, 44.2% proceed to investigate cardiovas-
cular anamnesis and 39.5% refer women to a cardiologist.
Interestingly, all these action habits were more frequently un-
dertaken in Eastern European countries and by radiologists
working in private hospitals and private practice. Such find-
ings may be partially explained considering that these three
geographic areas (Western Europe, Eastern Europe, and non-
European countries) do not mirror official indications, rather
reflect a similarity of routine practices both in screening and
diagnostic setting.
Italy, along with the UK, had the greater number of respon-
dents to this survey (53/378, 14.0% Italian and 38/378, 10.1%
English respondents), as for the greater number of members
within EUSOBI (187/1084, 17.2% Italian and 80/1084, 7.4%
English members). This result could also be influenced by the
lesser diffusion of organised screening programmes in some
countries, as well as by differences in the number of exami-
nations and allotted time performed in private setting, factors
which unfortunately do not emerge from our survey. Finally,
different socio-cultural contexts or medico-legal issues may
also come into play.
Most of the respondents, 64.8%, qualitatively describe
BAC as “present”, while just over a fourth assess them
through an ordinal visual scale, the latter undoubtedly
representing a considerable step from a mere subjective and
qualitative evaluation towards a semi-quantitative assessment.
Only one radiologist (0.4%) declared to manually perform a
quantitative assessment, while computer-aided tools were ab-
solutely missing.
Binary BAC classifications hinder the comprehensive strat-
ification of women into multiple cardiovascular risk levels and
the identifications of womenwho wouldmostly benefit from a
tailored disease prevention [7]. The target population for a
cost-effective further risk assessment is primarily represented
by individuals at intermediate cardiovascular risk; indeed, in a
low-risk population, the rationale for preventive intervention
is missing, while in a high-risk population, further risk assess-
ment would not reasonably impact on a formerly recommend-
ed pharmacological treatment [21]. Nevertheless, the major
source of bias for qualitative or semi-quantitative methods
for BAC evaluation has been—up to now—their poor repro-
ducibility [7, 22]. Albeit easily detectable on mammography,
BAC topological complexity and vessel overlap on two-
dimensional mammographic projections make both the iden-
tification and quantification of BAC quite difficult to stan-
dardise, preventing robust validation and subsequent clinical
application [5, 7]. A sound and reproducible BAC quantifica-
tion, ideally through a continuous scale, is paramount for car-
diovascular risk stratification. Valuable information on this
issue will probably come from the MINERVA study, the first
large prospective study using a continuous mass (in milli-
grams) score for BAC assessment. These results will hopeful-
ly contribute to determine whether this validated method [23]
is indeed capable of predicting coronary heart disease, cere-
brovascular disease, heart failure, peripheral vascular disease,
and total cardiovascular disease on a large population.
Answers to these questions will also clarify if adding BAC
burden classification to prediction models based on traditional
risk factors effectively stimulates a reclassification of cardio-
vascular disease risk in women [24].
An automated tool could also represent a useful solution for
BAC quantification and is what we must strive for. Recently,
the use of artificial intelligence systems for BAC segmenta-
tion was investigated. In particular, a deep convolutional neu-
ral network was trained to discriminate between BAC and
non-BAC pixels from digital mammography images,
obtaining good performances both in BAC detection and cal-
cium mass quantification [25]. However, such systems,
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although promising, are still far from being validated and sub-
sequently applied, large-scale studies being needed to obtain
further improvements.
Limitations of this survey include, first, a potential selection
bias among radiologist members of the EUSOBI, who of
course supposedly display special interest in breast imaging
and in keeping updated with correlated research on such topic.
Therefore, awareness about BAC meaning and reporting atti-
tude are potentially overestimated and not generalisable to the
whole radiological community. Secondly, the response rate was
below 50%, as indeed typically observed in similar surveys
[26], with our 35.2% response rate being higher than expected
and representing an excellent data. Finally, more detailed ques-
tions about education, habits, and technical challenges were
avoided to reach a good compliance in terms of response rate.
In conclusion, this survey illustrated that, among EUSOBI
members, more than 80% of respondents are aware of BAC
implications in terms of cardiovascular risk, and that more
than 60% include BAC on mammogram reports when they
are present. However, BAC quantitative estimates are not per-
formed, with very few exceptions.
Large-scale studies are now needed to ascertain the role of
BAC assessment in the comprehensive framework of female
cardiovascular disease prevention, provided that BAC quanti-
tative methods are available. Furthermore, efforts should be
pursued in discussing with women their BAC status and its
meaning. Reporting BAC may prove a step towards promot-
ing cardiovascular disease prevention in women via mam-
mography. This would ultimately confer the ability to con-
comitantly influence the course of two leading causes of death
in women, i.e. breast cancer and cardiovascular disease, to a
widely diffused and endorsed population-based screening
programme.
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